< Back to previous page
Researcher
Kaat Luyten
- Disciplines:Other chemical sciences, Chemical product design and formulation, Biomaterials engineering, Medical imaging and therapy, Medicinal products
Affiliations
- Radiopharmaceutical Research (Division)
Member
From3 Oct 2016 → 21 Mar 2022
Projects
1 - 1 of 1
- Design and development of a new vector platform for CXCR4-targeted molecular imaging and radionuclide therapyFrom1 Oct 2016 → 14 Jan 2022Funding: BOF - Doctoral projects
Publications
1 - 6 of 6
- Design and development of a new vector platform for CXCR4-targeted molecular imaging and radionuclide therapy(2022)
Authors: Kaat Luyten, Guy Bormans, Frederik Cleeren
- D-Peptide-Based Probe for CXCR4-Targeted Molecular Imaging and Radionuclide Therapy(2021)
Authors: Kaat Luyten, Tom Van Loy, Christopher Cawthorne, Christophe Deroose, Dominique Schols, Guy Bormans, Frederik Cleeren
- Synthetic Pept-Ins as a Generic Amyloid-Like Aggregation-Based Platform for In Vivo PET Imaging of Intracellular Targets(2021)
Authors: Kaat Luyten, Laleh Khodaparast, Ladan Khodaparast, Filip Claes, Rodrigo Gallardo, Michel Koole, Joost Schymkowitz, Guy Bormans, Frederic Rousseau
Pages: 2052 - 2064 - Evaluation of [11C]KB631 as a PET tracer for in vivo visualisation of HDAC6 in B16.F10 melanoma☆(2019)
Authors: Koen Vermeulen, Kaat Luyten, Guy Bormans
Pages: 1 - 11 - Evaluation of [11C]NMS-E973 as a PET tracer for in vivo visualisation of HSP90(2019)
Authors: Koen Vermeulen, Evelyne Naus, Kaat Luyten, Sofie Celen, Joost Schymkowitz, Frederic Rousseau, Guy Bormans
Pages: 554 - 572 - MOLECULAR IMAGING OF CARDIAC METABOLISM, INNERVATION, AND CONDUCTION(2017)
Authors: Kaat Luyten, Matthias Schönberger
Pages: 70 - 78